Axsome gains as narcolepsy therapy undergoes FDA review

Axsome Therapeutics (AXSM) stock gains as the FDA accepts the company's marketing application for its narcolepsy therapy ...
Neurology Advisor

FDA to Review Oral Treatment for Obstructive Sleep Apnea

The FDA has accepted Apnimed’s NDA for AD109 (aroxybutynin/atomoxetine), a potential first-in-class oral therapy for adults with obstructive sleep apnea.
Wareable

The best TENS unit for home use: Our favorite models and recommendations

Need a new TENS unit or buying your first one? Read our recommendations and discover our pick for the best TENS unit for home ...
Psychology Today

How Can a Drug Lasting Hours Change the Brain for Months?

The greatest therapeutic effects of psychedelics appear to occur long after the drug is gone. New research suggests they ...
Becker's Spine Review

The evidence gap behind spine’s most common postoperative devices

Much of the durable medical equipment routinely prescribed after cervical spine surgery is not well supported by clinical data, according to an analysis published in the Summer 2026 issue of Vertebral ...